TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06150391

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Visionary: computer exercises using dichoptic Gabor Patches and band-filtered noise masks
Description: Visionary exercises are computer gammified activities that run on a computer with internet connection to facilitate home therapy. Patient must wear anaglyph glasses. Visual stimuli consists in dichoptic Gabor Patches presented to the amblyopic eye. Frequency is adjusted to actual patient visual acuity, and contrast to actual patient performance (contrast sensitivity). A band-filtered noise mask at the same frequency than the Gabor patch is presented to the fellow eye in certain ocassions.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Visionary: computer exercises using dichoptic Gabor Patches and band-filtered noise masks
Description: Visionary exercises are computer gammified activities that run on a computer with internet connection to facilitate home therapy. Patient must wear anaglyph glasses. Visual stimuli consists in dichoptic Gabor Patches presented to the amblyopic eye. Frequency is adjusted to actual patient visual acuity, and contrast to actual patient performance (contrast sensitivity). A band-filtered noise mask at the same frequency than the Gabor patch is presented to the fellow eye in certain ocassions.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Visionary: computer exercises using dichoptic Gabor Patches and band-filtered noise masks
Description: Visionary exercises are computer gammified activities that run on a computer with internet connection to facilitate home therapy. Patient must wear anaglyph glasses. Visual stimuli consists in dichoptic Gabor Patches presented to the amblyopic eye. Frequency is adjusted to actual patient visual acuity, and contrast to actual patient performance (contrast sensitivity). A band-filtered noise mask at the same frequency than the Gabor patch is presented to the fellow eye in certain ocassions.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Patching
Description: PEDIG (Pediatric Eye Disease Investigator Group) recommended amblyopia treatment. Consist on covering a child's better-seeing eye with a patch for 2 hours per day for mild and moderate amblyopia or 6 hours per day for severe amblyopia

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Patching
Description: PEDIG (Pediatric Eye Disease Investigator Group) recommended amblyopia treatment. Consist on covering a child's better-seeing eye with a patch for 2 hours per day for mild and moderate amblyopia or 6 hours per day for severe amblyopia

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Patching
Description: PEDIG (Pediatric Eye Disease Investigator Group) recommended amblyopia treatment. Consist on covering a child's better-seeing eye with a patch for 2 hours per day for mild and moderate amblyopia or 6 hours per day for severe amblyopia
Study: NCT04800432

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: EUC
Description: Enhanced Usual Care is an abbreviated version of the full ADAPT+ intervention in which parents are engaged in a one-time, two hour information session to also learn knowledge and skills to improve the health and lifestyle behaviors for their child and for themselves.
Study: NCT06315712

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: inspiratory exercise
Description: The training consisted of 6 sets of 30 breaths per day, divided into 2 sessions per day. A one-minute rest interval between each set. Training was prescribed 5 days a week for 8 weeks

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Description: Four resistive exercises, aerobic exercise, and deep breathing exercises, five sessions per week for 8 weeks

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Description: Four resistive exercises, aerobic exercise, and deep breathing exercises, five sessions per week for 8 weeks
Study: NCT06049849

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Biophoton Energizing Brain and Whole Body
Description: The patient is to be energized within a strong biophoton field which is constantly generated by active biophoton generators.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Biophoton Energizing Brain and Whole Body
Description: The patient is to be energized within a strong biophoton field which is constantly generated by active biophoton generators.
Study: NCT06208514

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief pain exposure therapy (BPET)
Description: Participants will complete daily logs for 7-days pre-treatment baseline, along with 21 days during the intervention protocol, and 7 for days post-treatment.~Brief Pain Exposure Therapy will be given for 3 weeks, 1.5 hours per week, telehealth-based behavioral intervention for chronic pain. Session content will include pain neuroscience education, mindfulness meditation, and graded exposure techniques for improving tolerance of painful or feared activities. Participants will also be provided handouts and pre-recorded meditation and imagery scripts that participants can use to facilitate between-session practices. In addition, participants will complete surveys through-out the study.
Study: NCT06410274

Intervention type: DEVICE
Intervention: Transcranial Doppler ultrasonography (TCD)
Description: TCD will be used to measure cerebral blood velocity (CBv) in the middle and posterior cerebral arteries (MCA and PCA). Following confirmation of a suitable TCD window, participants will undergo a ten-minute rest period in the supine or semi-supine position. Continuous measurements of CBv, blood pressure (BP), heart rate, and end-tidal carbon dioxide will be recorded. Baseline BP will be measured using an automated BP device prior to each recording to allow calibration of the files offline for analysis. This will occur at the first visit and at follow-up, 4-7 days post-onset of intracerebral haemorrhage.
Study: NCT06417424

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: gastrointestinal external stimulation
Description: We used the device Gastrointestinal multifunctional therapeutic instrument. The positive pole was placed 1 to 2cm above the umbilicus, and the negative pole was placed 4 to 10 cm to the right of the midpoint between the xiphoid process and the umbilicus.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: gastrointestinal external stimulation
Description: We used the device Gastrointestinal multifunctional therapeutic instrument. The positive pole was placed 1 to 2cm above the umbilicus, and the negative pole was placed 4 to 10 cm to the right of the midpoint between the xiphoid process and the umbilicus.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: gastrointestinal external stimulation
Description: We used the device Gastrointestinal multifunctional therapeutic instrument. The positive pole was placed 1 to 2cm above the umbilicus, and the negative pole was placed 4 to 10 cm to the right of the midpoint between the xiphoid process and the umbilicus.
Study: NCT05378191

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: COMIRNATY
Description: One dose of COMIRNATY
Study: NCT06185725

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Modified Perichondral Approach Thoracoabdominal Nerve Block
Description: M-TAPA block will be performed to Group M-TAPA at the end of the surgery, using US (Vivid Q) while the patient is in the supine position After providing aseptic conditions, the high frequency linear US probe (11-12 MHz, Vivid Q) will be covered with a sterile sheath, and an 80 mm block needle (Braun 360°) will be used. The US probe will be placed in the sagittal plane where the midclavicular line intersects with the costal cartilage corresponding to the costochondral angle. Using the In Plane technique, the probe is gently pushed to visualize the lower part of the costochondral angle at the central level, advancing the block needle in the caudal-cranio direction, 5 ml of saline will be injected into the layer between the transverse abdominal muscle and the lower plane of the costal cartilage, and the block location will be confirmed. After the block location is confirmed, a total of 20 ml + 20 ml of 0.25% bupivacaine (total 40 ml for both sides) will be injected bilaterally

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Transversus Abdominal Plane Block
Description: TAP block will be performed to Group TAP at the end of the surgery, using US (Vivid Q) while the patient is in the supine position. After providing aseptic conditions, the high frequency linear US probe (11-12 MHz, Vivid Q) will be covered with a sterile sheath, and an 80 mm block needle (Braun 360°) will be used. USG will be placed transversely on the mid-axillary line between the iliac crest and subcostal planes. Using the In Plane technique, the block needle will be advanced into the fascial plane between the internal oblique and transversus abdominis muscles and the location will be confirmed by administering 5 ml of saline. The block needle will be advanced into the fascial plane between the internal oblique and transversus abdominis muscles and the location will be confirmed by administering 5 ml of saline.and than 20 ml of 0.25% bupivacaine (total 40 ml for both sides) will be injected bilaterally
Study: NCT05050331

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Muscle Energy Technique
Description: MET involves patient-generated muscle contractions 10-20% maximum voluntary contraction from a specific position and direction, resisted by the therapist to facilitate muscle relaxation and lengthening

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Trigger Point Release
Description: Trigger point release involved applying 90 seconds of sustained thumb pressure to the trigger point, repeated three times with 30-second relaxation intervals, followed by three caudal-to-cranial longitudinal strokes along the taut band.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Self-Stretching of Calf and Plantar Fascia
Description: Participants performed a self-stretching program, comprising 5 repetitions of 20 seconds of stretching and 20 seconds of relaxation, twice daily

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Self-Stretching of Calf and Plantar Fascia
Description: Participants performed a self-stretching program, comprising 5 repetitions of 20 seconds of stretching and 20 seconds of relaxation, twice daily
Study: NCT04211753

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual (schema therapy)
Description: weekly group psychotherapy and bimonthly individual psychotherapy

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment as usual (schema therapy)
Description: weekly group psychotherapy and bimonthly individual psychotherapy

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mobile app
Description: Medical device for crisis intervention
Study: NCT06463808

Intervention type: DRUG
Intervention: Recombinant Human Brain Natriuretic Peptide
Description: we divide our subjects into two groups;one is required to take recombinant human brain natriuretic peptide,the other is not required to take recombinant human brain natriuretic peptide
Study: NCT06306807

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise program including active cervical range of motion, strengthening, and posture correction exercises and ergonomic modifications
Description: Active cervical range of motion exercise program consists of the general range of movement for flexors, extensors, both sides flexors, and rotator neck muscles. Participants were instructed to perform exercises in a sitting position, but they were allowed to perform exercises in supine and prone lying if they had problems with sitting position. Strengthening exercises were planned for weak, lengthened, inhibited muscles e.g. Longus colli, and longus capitis. Chin tucks, chin tucks against gravity, and chin nod exercises were selected. Ergonomic modifications while using a smartphone were taught such as taking breaks and changing positions frequently while using a smartphone, avoiding cradling the phone between your ear and shoulder, choosing a smartphone that fits your hands properly, holding the smartphone near chest level rather than waist level, and using features including predictive text or auto-complete tools

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise program including active cervical range of motion, strengthening, and posture correction exercises and ergonomic modifications
Description: Active cervical range of motion exercise program consists of the general range of movement for flexors, extensors, both sides flexors, and rotator neck muscles. Participants were instructed to perform exercises in a sitting position, but they were allowed to perform exercises in supine and prone lying if they had problems with sitting position. Strengthening exercises were planned for weak, lengthened, inhibited muscles e.g. Longus colli, and longus capitis. Chin tucks, chin tucks against gravity, and chin nod exercises were selected. Ergonomic modifications while using a smartphone were taught such as taking breaks and changing positions frequently while using a smartphone, avoiding cradling the phone between your ear and shoulder, choosing a smartphone that fits your hands properly, holding the smartphone near chest level rather than waist level, and using features including predictive text or auto-complete tools

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PNF exercise program
Description: The contract-relax technique for the neck extension pattern and the replication technique for the scapular posterior elevation pattern were used.
Study: NCT04765683

Intervention type: OTHER
Intervention: questionnaire
Description: Survey of views on outpatient consultation format

Intervention type: OTHER
Intervention: questionnaire
Description: Survey of views on outpatient consultation format
Study: NCT05220436

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DISCOVER workshop programme
Description: See arm description. The manualised group workshop day is informed by Cognitive Behaviour Therapy and Acceptance \& Commitment Therapy principles.
Study: NCT05180188

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Training
Description: In the 8-week training period, participants will have three training sessions with a duration of 30 minutes at 70% of VO2peak per week.
Study: NCT05196568

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fasting mimicking diet
Description: Women will be given three administrations of fasting mimicking diet once a month
Study: NCT05773144

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Description: Moderate- to vigorous-intensity aerobic exercise

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Description: Moderate- to vigorous-intensity aerobic exercise

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Description: Moderate- to vigorous-intensity aerobic exercise

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Description: Moderate- to vigorous-intensity aerobic exercise

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Progressive stretching
Description: Static stretching of eight major muscle groups
Study: NCT05494385

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Preoperative Gabapentin/Postoperative Placebo
Description: Postoperatively, this group will receive scheduled acetaminophen and ibuprofen every 6 hours, in addition to placebo every 12 hours. The placebo is encapsulated to appear identical to the active drug. This group will have oxycodone 5 mg every 6 hours as needed for pain.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Preoperative Gabapentin/Postoperative Gabapentin
Description: Postoperatively, this group will receive scheduled acetaminophen and ibuprofen every 6 hours, in addition to gabapentin every 12 hours. The gabapentin is encapsulated to appear identical to the placebo. This group will have oxycodone 5 mg every 6 hours as needed for pain.
Study: NCT06476106

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Venoconstrictive Thigh Cuff (VTC)
Description: The VTC is an adjustable fabric cuff that is worn on the upper thighs to retain some fluid in the legs. It consists of wide straps and a buckle which allow it to be tightened, then velcro to secure the strap in the tightened position. There is also lacing that can be tightened for micro adjustments. Imbedded within the fabric strap is a bladder that is not used for increasing tightness but allows the pressure of the cuff to be measured and tracked.
Study: NCT04967391

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tumescence During STSG Harvest
Description: Tumescence injections performed prior to STSG harvest
Study: NCT06117618

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nurse SIRS alert
Description: An electronic alert will display when a nurse opens the patient chart of a patient who meets SIRS criteria.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nurse SIRS alert
Description: An electronic alert will display when a nurse opens the patient chart of a patient who meets SIRS criteria.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prescribing clinician SIRS alert
Description: An electronic alert will display when a prescribing clinician opens the patient chart of a patient who meets SIRS criteria.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prescribing clinician SIRS alert
Description: An electronic alert will display when a prescribing clinician opens the patient chart of a patient who meets SIRS criteria.
Study: NCT06188910

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neurofeedback
Description: Conducting neurofeedback sessions guided by a researcher

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Health education
Description: Health education on mobile phone addiction
Study: NCT04792645

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Pill that contains no medicine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Memantine
Description: Cognition-enhancing medication
Study: NCT05398172

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MorpheusV Applicator
Description: Eligible subjects will receive 3 treatments 4 weeks apart with the MorpheusV Applicator according to the study protocol
Study: NCT05403385

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: inupadenant
Description: Adenosine 2a receptor antagonist

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: inupadenant
Description: Adenosine 2a receptor antagonist

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: matched placebo capsule to inupadenant

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: standard of care chemotherapeutic, alkylating agent

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: standard of care chemotherapeutic, alkylating agent

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Carboplatin
Description: standard of care chemotherapeutic, alkylating agent

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: standard of care chemotherapeutic, anti-metabolite

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: standard of care chemotherapeutic, anti-metabolite

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Pemetrexed
Description: standard of care chemotherapeutic, anti-metabolite
Study: NCT06242574

Intervention type: OTHER
Intervention: Survey
Description: Each group will have to complete a questionnaire online, taking about 30 minutes.

Intervention type: OTHER
Intervention: Survey
Description: Each group will have to complete a questionnaire online, taking about 30 minutes.

Intervention type: OTHER
Intervention: Survey
Description: Each group will have to complete a questionnaire online, taking about 30 minutes.
Study: NCT05803252

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Focused Acceptance and Commitment Therapy
Description: FACT aims to increase one's psychological flexibility so that one will not generate feelings of distress and suffering when confronted with painful life situations. The intervention of this study will follow the FACT principles laid out by Strosahl, Robinson and Gustavsson to increase parents' psychological flexibility. Three core processes influence one's psychological flexibility: awareness, openness, and engagement.~The key objectives of each core process are:~1. Awareness: Able to experience the present moment, able to take perspective on self~2. Openness: Able to detach distressing private experiences and associated rules, able to take a non-judgemental, accepting stance towards painful material~3. Engagement: Exhibits strong connection with values, able to sustain values-consistent action

Intervention type: OTHER
Group type: OTHER
Intervention: Waitlist Control
Description: The waitlist control group participants will commence their FACT intervention immediately after they complete their follow-up assessment.
Study: NCT04340752

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indocyanine Green
Description: ICG is an injectable fluorescent pigment that binds to proteins in the blood and allows surgery teams to view blood vessels with greater precision. The ICG will not affect the course of the operative or postoperative period, and will be injected intravenously prior to the actual repair

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indocyanine Green
Description: ICG is an injectable fluorescent pigment that binds to proteins in the blood and allows surgery teams to view blood vessels with greater precision. The ICG will not affect the course of the operative or postoperative period, and will be injected intravenously prior to the actual repair

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indocyanine Green
Description: ICG is an injectable fluorescent pigment that binds to proteins in the blood and allows surgery teams to view blood vessels with greater precision. The ICG will not affect the course of the operative or postoperative period, and will be injected intravenously prior to the actual repair
Study: NCT05701189

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efgartigimod Alfa-Fcab
Description: Efgartigimod is an anti-neonatal Fc receptor (FcRn) immunoglobulin G1 Fc fragment. The FcRn plans a critical role in extending the half-life of IgGs by rescuing them from lysosomal degradation. Antibodies that bind and subsequently block the FcRn with high affinity result in IgGs being degraded more rapidly instead of salvaged. This approach has been shown to be beneficial in the antibody-mediated disorder myasthenia gravis.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous Immunoglobulin (IVIg)
Description: IVIg is the standard-of-care treatment for GBS.